Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1980 Jul;41(1):166–172.

In vivo and in vitro action of chloroquine on surface markers of human peripheral lymphocytes.

P S Nagarkatti, M Nagarkatti, V C Jain
PMCID: PMC1536933  PMID: 7438549

Abstract

Chloroquine was administered orally to twenty normal individuals and the effect of the drug on surface markers of peripheral bloof lymphocytes was studied. The total number of circulating lymphocytes and leucocytes in the blood did not change significantly after chloroquine administration. However, there was a significant fall in the percentage and number of lymphocytes with erythrocyte (E) and C'3 markers and an increase in cells lacking both these markers. In vitro experiments were carried out to study the mechanism of action of the drug on the expression of the lymphocyte receptors. Lymphocytes treated with chloroquine in vitro failed to show any change in their capacity to bind erythrocytes or erythrocytes coated with Ab and complement. The sera from chloroquine-treated individuals failed to show any factor inhibiting E and EAC rosette formation. The studies indicate that chloroquine may not act directly on the lymphocyte surface markers and cause inhibition of their expression but that it may act in some indirect way affecting one or more of the many factors involved in the normal expression of the markers.

Full text

PDF
166

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. COHEN S. N., YIELDING K. L. SPECTROPHOTOMETRIC STUDIES OF THE INTERACTION OF CHLOROQUINE WITH DEOXYRIBONUCLEIC ACID. J Biol Chem. 1965 Jul;240:3123–3131. [PubMed] [Google Scholar]
  2. COWLEY R. G., MYERS J. E., Jr Chloroquine in the treatment of infectious mononucleosis. Ann Intern Med. 1962 Dec;57:937–945. doi: 10.7326/0003-4819-57-6-937. [DOI] [PubMed] [Google Scholar]
  3. D'Souza M. B., Nagarkatti P. S., Rao K. M. Subpopulation of peripheral blood lymphocytes in human encephalitis caused by group B arboviruses (Dengue, West Nile and Japanese B encephalitis. J Hyg Epidemiol Microbiol Immunol. 1979;23(1):59–66. [PubMed] [Google Scholar]
  4. Forbes I. J., Smith J. L. Effects of anti-inflammatory drugs on lymphocytes. Lancet. 1967 Aug 12;2(7511):334–337. doi: 10.1016/s0140-6736(67)90173-0. [DOI] [PubMed] [Google Scholar]
  5. Gluckman J. C., Beaufils H., Sanchez F. Inhibition of complement-dependent lymphocyte rosette formation by sera of patients with chronic glomerulonephritis. Clin Exp Immunol. 1976 Nov;26(2):247–252. [PMC free article] [PubMed] [Google Scholar]
  6. HURVITZ D., HIRSCHHORN K. SUPPRESSION OF IN VITRO LYMPHOCYTE RESPONSES BY CHLOROQUINE. N Engl J Med. 1965 Jul 1;273:23–26. doi: 10.1056/NEJM196507012730105. [DOI] [PubMed] [Google Scholar]
  7. Jondal M., Klein G. Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J Exp Med. 1973 Dec 1;138(6):1365–1378. doi: 10.1084/jem.138.6.1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Karmali R. A., Horrobin D. F., Menezes J., Patel P., Musto J. Chloroquine enhances Epstein-Barr virus expression. Nature. 1978 Oct 5;275(5679):444–445. doi: 10.1038/275444a0. [DOI] [PubMed] [Google Scholar]
  9. Mogensen C. E. The glomerular permeability determined by dextran clearance using Sephadex gel filtration. Scand J Clin Lab Invest. 1968;21(1):77–82. doi: 10.3109/00365516809076979. [DOI] [PubMed] [Google Scholar]
  10. Nagarkatti P. S., Rao S. S. Cell-mediated immunity to homologous spermatozoa following vasectomy in the human male. Clin Exp Immunol. 1976 Nov;26(2):239–242. [PMC free article] [PubMed] [Google Scholar]
  11. PARKER F. S., IRVIN J. L. The interaction of chloroquine with nucleic acids and nucleoproteins. J Biol Chem. 1952 Dec;199(2):897–909. [PubMed] [Google Scholar]
  12. POMERANZ J. R., SMITH E. W., MALAK J. A. STUDIES ON THE MODE OF ACTION OF CHLOROQUINE. Bull Johns Hopkins Hosp. 1963 Nov;113:273–290. [PubMed] [Google Scholar]
  13. WEISSMANN G. LABILIZATION AND STABILIZATION OF LYSOSOMES. Fed Proc. 1964 Sep-Oct;23:1038–1044. [PubMed] [Google Scholar]
  14. Ward P. A. The chemosuppression of chemotaxis. J Exp Med. 1966 Aug 1;124(2):209–226. doi: 10.1084/jem.124.2.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Whitehouse M. W. Some biochemical and pharmacological properties of anti-inflammatory drugs. Fortschr Arzneimittelforsch. 1965;8:321–429. doi: 10.1007/978-3-0348-7056-6_5. [DOI] [PubMed] [Google Scholar]
  16. Yefenof E., Klein G. Membrane receptor stripping confirms the association between EBV receptors and complement receptors on the surface of human B lymphoma lines. Int J Cancer. 1977 Sep 15;20(3):347–352. doi: 10.1002/ijc.2910200305. [DOI] [PubMed] [Google Scholar]
  17. Zvaifler N. J. Antimalarials in the treatment of rheumatoid arthritis. Mod Treat. 1971 Nov;8(4):769–777. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES